Zhejiang Huahai Pharmaceutical Co., Ltd. (SHA:600521)

China flag China · Delayed Price · Currency is CNY
18.70
-0.77 (-3.95%)
Jun 26, 2025, 11:29 AM CST
5.47%
Market Cap 28.81B
Revenue (ttm) 9.42B
Net Income (ttm) 1.15B
Shares Out 1.48B
EPS (ttm) 0.79
PE Ratio 24.66
Forward PE 22.16
Dividend 0.20 (1.02%)
Ex-Dividend Date Jul 10, 2024
Volume 25,921,774
Average Volume 56,072,414
Open 19.14
Previous Close 19.47
Day's Range 18.40 - 19.15
52-Week Range 13.49 - 21.55
Beta 0.38
RSI 58.23
Earnings Date Aug 29, 2025

About SHA:600521

Zhejiang Huahai Pharmaceutical Co., Ltd. operates as a pharmaceutical company in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also engages in packaging components business, such as high-density polyethylene bottles and polypropylene caps. In addition, the company provides contract manufacturing and other services. Further, it is involved in import and export trade services. Pharmaceutical Co., Ltd. was founded in 1989 and is headquartere... [Read more]

Sector Healthcare
Founded 1989
Employees 9,065
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600521
Full Company Profile

Financial Performance

In 2024, SHA:600521's revenue was 9.55 billion, an increase of 14.91% compared to the previous year's 8.31 billion. Earnings were 1.12 billion, an increase of 34.74%.

Financial Statements

News

There is no news available yet.